These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17097693)

  • 1. Impairments of social behavior and memory after neonatal gastrin-releasing peptide receptor blockade in rats: Implications for an animal model of neurodevelopmental disorders.
    Presti-Torres J; de Lima MN; Scalco FS; Caldana F; Garcia VA; Guimarães MR; Schwartsmann G; Roesler R; Schröder N
    Neuropharmacology; 2007 Mar; 52(3):724-32. PubMed ID: 17097693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-associative learning and anxiety in rats treated with a single systemic administration of the gastrin-releasing peptide receptor antagonist RC-3095.
    Martins MR; Reinke A; Valvassori SS; Machado RA; Quevedo J; Schwartsmann G; Roesler R
    Peptides; 2005 Dec; 26(12):2525-9. PubMed ID: 16023260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term behavioral effects of neonatal blockade of gastrin-releasing peptide receptors in rats: similarities to autism spectrum disorders.
    Merali Z; Presti-Torres J; Mackay JC; Johnstone J; Du L; St-Jean A; Levesque D; Kent P; Schwartsmann G; Roesler R; Schroder N; Anisman H
    Behav Brain Res; 2014 Apr; 263():60-9. PubMed ID: 24462726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite effects of low and high doses of the gastrin-releasing peptide receptor antagonist RC-3095 on memory consolidation in the hippocampus: possible involvement of the GABAergic system.
    Dantas Ados S; Luft T; Henriques JA; Schwartsmann G; Roesler R
    Peptides; 2006 Sep; 27(9):2307-12. PubMed ID: 16650508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gastrin-releasing peptide receptor antagonist blocks D-amphetamine-induced hyperlocomotion and increases hippocampal NGF and BDNF levels in rats.
    Kauer-Sant'Anna M; Andreazza AC; Valvassori SS; Martins MR; Barbosa LM; Schwartsmann G; Roesler R; Quevedo J; Kapczinski F
    Peptides; 2007 Jul; 28(7):1447-52. PubMed ID: 17629354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone reverses the memory impairment induced by antagonism of hippocampal gastrin-releasing peptide receptors.
    Venturella R; Lessa D; Luft T; Roozendaal B; Schwartsmann G; Roesler R
    Peptides; 2005 May; 26(5):821-5. PubMed ID: 15808912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RC-3095, a bombesin/gastrin-releasing peptide receptor antagonist, impairs aversive but not recognition memory in rats.
    Roesler R; Kopschina MI; Rosa RM; Henriques JA; Souza DO; Schwartsmann G
    Eur J Pharmacol; 2004 Feb; 486(1):35-41. PubMed ID: 14751406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for hippocampal gastrin-releasing peptide receptors in extinction of aversive memory.
    Luft T; Flores DG; Vianna MR; Schwartsmann G; Roesler R; Izquierdo I
    Neuroreport; 2006 Jun; 17(9):935-9. PubMed ID: 16738491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibition prevents the impairing effects of hippocampal gastrin-releasing peptide receptor antagonism on memory consolidation and extinction.
    Petry FS; Dornelles AS; Lichtenfels M; Valiati FE; de Farias CB; Schwartsmann G; Parent MB; Roesler R
    Behav Brain Res; 2016 Jul; 307():46-53. PubMed ID: 27025446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an antagonist of the gastrin-releasing peptide receptor in an animal model of uveitis.
    Pereira DV; Steckert AV; Mina F; Petronilho F; Roesler R; Schwartsmann G; Ritter C; Dal-Pizzol F
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5300-3. PubMed ID: 19516017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue of social behavior impairment by clozapine and alterations in the expression of neuronal receptors in a rat model of neurodevelopmental impairment induced by GRPR blockade.
    Presti-Torres J; Garcia VA; Dornelles A; Halmenschlager LH; Alcalde LA; Vedana G; Rico EP; Bogo MR; Schwartsmann G; Roesler R; Schröder N
    J Neural Transm (Vienna); 2012 Mar; 119(3):319-27. PubMed ID: 21847557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms mediating gastrin-releasing peptide receptor modulation of memory consolidation in the hippocampus.
    Roesler R; Luft T; Oliveira SH; Farias CB; Almeida VR; Quevedo J; Dal Pizzol F; Schröder N; Izquierdo I; Schwartsmann G
    Neuropharmacology; 2006 Aug; 51(2):350-7. PubMed ID: 16735043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of postnatal blockade of N-methyl-D-aspartate receptors on rat behavior: a search for a new developmental model of schizophrenia.
    Wedzony K; Fijal K; Mackowiak M; Chocyk A; Zajaczkowski W
    Neuroscience; 2008 Jun; 153(4):1370-9. PubMed ID: 18434025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bombesin/gastrin releasing peptide receptor antagonist RC-3095 blocks apomorphine but not MK-801-induced stereotypy in mice.
    Meller CA; Henriques JA; Schwartsmann G; Roesler R
    Peptides; 2004 Apr; 25(4):585-8. PubMed ID: 15165713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahippocampal infusion of the bombesin/gastrin-releasing peptide antagonist RC-3095 impairs inhibitory avoidance retention.
    Roesler R; Meller CA; Kopschina MI; Souza DO; Henriques JA; Schwartsmann G
    Peptides; 2003 Jul; 24(7):1069-74. PubMed ID: 14499286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic fibroblast growth factor prevents the memory impairment induced by gastrin-releasing peptide receptor antagonism in area CA1 of the rat hippocampus.
    Preissler T; Luft T; Kapczinski F; Quevedo J; Schwartsmann G; Roesler R
    Neurochem Res; 2007 Aug; 32(8):1381-6. PubMed ID: 17406984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoinositide 3-kinase is required for bombesin-induced enhancement of fear memory consolidation in the hippocampus.
    Roesler R; Valvassori SS; Castro AA; Luft T; Schwartsmann G; Quevedo J
    Peptides; 2009 Jun; 30(6):1192-6. PubMed ID: 19463755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a gastrin-releasing peptide receptor antagonist on D-amphetamine-induced oxidative stress in the rat brain.
    Valvassori SS; Moretti M; Kauer-Sant'Anna M; Roesler R; Petronilho F; Schwartsmann G; Kapczinski F; Dal-Pizzol F; Quevedo J
    J Neural Transm (Vienna); 2010 Mar; 117(3):309-16. PubMed ID: 20131069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrin-releasing peptide receptor antagonist or N-acetylcysteine combined with omeprazol protect against mitochondrial complex II inhibition in a rat model of gastritis.
    Rezin GT; Petronilho FC; Araújo JH; Gonçalves CL; Daufenbach JF; Cardoso MR; Roesler R; Schwartsmann G; Dal-Pizzol F; Streck EL
    Basic Clin Pharmacol Toxicol; 2011 Mar; 108(3):214-9. PubMed ID: 21138529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal gastrin-releasing peptide receptor blockade reduces maternal odor preference in rats.
    Garcia VA; Dornelles AS; Presti-Torres J; Alcalde LA; Halmenschlager LH; Schwartsmann G; Roesler R; Lucion AB; Schröder N
    Behav Brain Res; 2010 Dec; 214(2):456-9. PubMed ID: 20678987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.